<DOC>
	<DOCNO>NCT00934492</DOCNO>
	<brief_summary>This trial aim test hypothesis mortality among Kenyan child severe malnutrition follow initial stabilisation due ongoing vulnerability infectious disease , long term daily co-trimoxazole prophylaxis reduce mortality . The objective conduct randomize , double blind , placebo-controlled trial cotrimoxazole prophylaxis 6 month among HIV-uninfected child severe malnutrition follow stabilization . The primary outcome survival one year . Secondary outcome toxicity , growth , frequency cause hospitalisation microbial resistance antibiotic . Cotrimoxazole strike protective efficacy mortality among child HIV , despite alter underlie immune deficiency . It hypothesise co-trimoxazole prophylaxis similar effect child immunocompromised severe malnutrition . Worldwide , severe malnutrition commoner HIV childhood co-trimoxazole cheap widely available , make easily translatable policy .</brief_summary>
	<brief_title>Cotrimoxazole Prophylaxis Severely Malnourished Children</brief_title>
	<detailed_description>Malnutrition important underlying risk factor childhood death develop country . Severely malnourished child greatly increase risk death infectious disease community , hospital follow discharge . Malnutrition infection synergistic , part malnutrition cause secondary immune deficiency , whilst infection cause loss diversion nutrient . This synergy exacerbate high level exposure pathogen . Among child treat severe malnutrition Africa , mortality follow discharge hospital range 8 % 41 % . Cotrimoxazole synthetic antibacterial combination block two step folate metabolism involve biosynthesis nucleic acid proteins essential many bacteria parasite , include Plasmodium falciparum . It cheap , widely available establish safety profile African population . Cotrimoxazole prophylaxis dramatically reduce mortality among child HIV , irrespective degree immune suppression . The primary effect reduce bacterial infection , especially pneumonia . effect demonstrate area high level cotrimoxazole resistance bacteria . It also widely use developed country among child immune deficiency prevent infection . Children severe malnutrition immune deficient , evidence susceptibility infectious disease , may therefore benefit daily antimicrobial prophylaxis . The objective conduct randomize , double blind , placebo-controlled trial cotrimoxazole prophylaxis 6 month among HIV-uninfected child severe malnutrition follow stabilization . The primary outcome survival one year . Secondary outcome toxicity , growth , hospitalisation , microbial resistance carriage pathogenic organism marker inflammation immune function . On 26th September 2012 , advice independent senior statistician review actual event rate control arm , rate recruitment loss follow , Trial Steering Committee recommend trial team recruit least 1750 participant achieve original objective &gt; 90 % power detect reduction mortality 12 month follow 33 % . Recruitment stop 31st March 2013 1781 participant .</detailed_description>
	<mesh_term>Nutrition Disorders</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Age 2 month 5 year Admitted hospital Severe malnutrition : age 6 month 5 year : MUAC &lt; 11cm ; age 2 6 month : MUAC age &lt; 3 z score compare WHO growth standard ; kwashiorkor age ( define current WHO guideline ) enrollment 24th March 2011 . Severe malnutrition : age 6 month 5 year : MUAC &lt; 11.5cm ; age 2 6 month : MUAC &lt; 11.0cm ; kwashiorkor age ( define current WHO guideline ) enrollment 24th March 2011 , follow protocol amendment . HIV rapid test negative , 18 month , PCR negative long breastfeed least 6 week Planning remain within study area willing come protocol specify visit Refusal give inform consent Cotrimoxazole specifically contraindicate ( e.g . porphyria ) Known hypersensitivity reaction sulpha drug trimethoprim</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Malnutrition</keyword>
	<keyword>Wasting</keyword>
	<keyword>Kwashiorkor</keyword>
	<keyword>Immune deficiency</keyword>
	<keyword>Infection</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Mortality</keyword>
	<keyword>Kenya</keyword>
</DOC>